compounded vs branded is a regulatory question not a pharmacology one, right?
these get discussed like theyre different drugs and i dont think thats the right frame.
the molecule can be the same. what differs is the pathway: an approved product has a reviewed manufacturing process, a defined spec, batch release testing and a legal framework around whats in the vial. a compounded preparation sits under a different regime with different oversight.
so the meaningful question isnt "does compounded sema work". its the same molecule, if it is in fact that molecule at the stated amount. the question is what assurance exists that it is.
thats a supply chain and oversight question, and its important, but framing it as pharmacology confuses everything.
deliberately not naming or comparing suppliers, thats not what this forum is for. am i missing something?